Differential considerations include other histiocytic lesions, Rosai-Dorfman disease, and infectious causes. The primary non-Langerhans histiocytic lesion to consider in this type of case is reticulohistiocytoma. Reticulohistiocytoma, in contrast to JXG, lacks Touton giant cells at all stages of its evolution and characteristically is composed of large histiocytes with ground glass cytoplasm. Immunohistochemical analysis is not particularly helpful in differentiating between reticulohistiocytoma and JXG. Staining with antibodies, especially with macrophage markers (eg, CD68 and KP-1), is an ancillary technique and is only helpful to broadly classify the lesion as histiocytic in origin.13 Juvenile xanthogranuloma should also be differentiated from Langerhans histiocytosis. This distinction is facilitated with the use of immunohistochemical markers, because, unlike non-Langerhans lesions, Langerhans histiocytic lesions stain positive for S100 protein and CD1. This is an important distinction as Langerhans histiocytosis tends to be progressive in contrast to the non-Langerhans histiocytic disorders, which are usually self-limited in nature. Rosai-Dorfman disease and infection are other potential considerations in the differential diagnosis. Rosai-Dorfman disease, however, does not demonstrate the Touton giant cells typical of JXG and is characterized by lymphocytophagocytosis (emperipolesis) by sinus histiocytes, which are not a specific but a constant feature. The well-circumscribed, dome-shaped appearance of the lesion, the infiltrate abutting but not invading the overlying epidermis, and the presence of Touton giant cells, all of which are characteristic of JXG, ruled out an infectious origin in the present case.